申请人:Merrell Pharmaceuticals Inc.
公开号:US05965550A1
公开(公告)日:1999-10-12
The invention discloses 3-ketosteroids of the following formula used to inhibit steroid C.sub.17-20 lyase: ##STR1## wherein R is OH, C.sub.1 -C.sub.6 alkanoyl, C.sub.1 -C.sub.6 alkanoyloxy, C.sub.1 -C.sub.4 alkanol, COCH.sub.2 OH, CO.sub.2 H, CONR.sub.7 R.sub.8, cyclopropyloxy, cyclopropylamino, acetylthioalkane, 2,2-dimethyldioxolan4-yl, 1,2-dihydroxyethyl and C.sub.1-4 alkylthiol; R.sub.1 is hydrogen, hydroxy or C.sub.1-6 alkyl; R and R.sub.1 together may indicate .dbd.O, that is an oxygen double bonded to the 17 carbon; R.sub.2, R.sub.3, and R.sub.4 are each independently hydrogen or C.sub.1 -C.sub.6 alkyl; R.sub.5 and R.sub.6 are each independently hydrogen or OH; R.sub.5 and R.sub.6 together may indicate .dbd.O, that is an oxygen double bonded to the 11 carbon; R.sub.7 is hydrogen or C.sub.1 -C.sub.8 alkyl; R.sub.8 is C.sub.1 -C.sub.8 alkyl; and with the proviso that, when R is OH, then R.sub.1 is hydrogen; and with the proviso that, when R.sub.5 is OH, then R.sub.6 is hydrogen.
该发明揭示了以下公式的3-酮类固醇,用于抑制类固醇C.sub.17-20裂解酶:其中R为OH,C.sub.1-C.sub.6烷酰基,C.sub.1-C.sub.6烷酰氧基,C.sub.1-C.sub.4烷醇,COCH.sub.2OH,CO.sub.2H,CONR.sub.7R.sub.8,环丙氧基,环丙基氨基,乙酰硫代烷,2,2-二甲基二氧杂环戊烷-4-基,1,2-二羟乙基和C.sub.1-4烷基硫醇;R.sub.1为氢,羟基或C.sub.1-6烷基;R和R.sub.1一起可能表示.dbd.O,即与第17碳形成氧双键;R.sub.2,R.sub.3和R.sub.4分别独立地为氢或C.sub.1-C.sub.6烷基;R.sub.5和R.sub.6分别独立地为氢或OH;R.sub.5和R.sub.6一起可能表示.dbd.O,即与第11碳形成氧双键;R.sub.7为氢或C.sub.1-C.sub.8烷基;R.sub.8为C.sub.1-C.sub.8烷基;并且在R为OH时,R.sub.1为氢;在R.sub.5为OH时,R.sub.6为氢。